Spleen-Preserving No. 10 Lymph Node Dissection in Gastric Cancer

Status Recruiting

Clinical Trial Summary

This study is to conduct a randomized controlled trial of two kinds of radical gastrectomy for patients with proximal gastric cancer. One is laparoscopic D2 radical total gastrectomy combined with spleen-preserving No.10 lymph node dissection , another one is laparoscopic D2 radical total gastrectomy without clearing the No. 10 lymph nodes of the spleen. We explore the effect of the two procedures on the survival of patients, as well as the surgical complications associated with the two procedures, the number of lymph node dissection, the operation time and the amount of intraoperative blood loss. Furthermore, we also want to discuss the application value of laparoscopic lymph node dissection for spleen preservation in radical gastrectomy for proximal gastric cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04050787
Study type	Interventional
Source	First Hospital of Jilin University
Contact	Jian Suo, Ph.D.
Phone	?181 8687 1293?
Email	suojian0066@126.com
Status	Recruiting
Phase	N/A
Start date	July 21, 2019
Completion date	May 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04025840` - Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery	Phase 4
Completed	`NCT04111926` - Intraoperative Dexmedetomidine and Long-term Outcomes in Elderly After Major Surgery	Phase 4
Recruiting	`NCT04101760` - Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer	Phase 3
Withdrawn	`NCT03342300` - Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma	Phase 2/Phase 3
Recruiting	`NCT03910140` - TILA-TACE in Treatment of Hepatocellular Carcinoma	N/A
Completed	`NCT03923400` - Jejunoileal vs Gastric GIST in the Era of Imatinib.
Withdrawn	`NCT02201381` - Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer	Phase 3
Recruiting	`NCT05392257` - Efficacy and Safety of Rituximab Plus Zanubrutinib and Lenalidomide for Relapsed and Refractory Diffuse Large B Cell Lymphoma, a Multicenter, Open and Prospective Clinical Trial	Phase 2
Recruiting	`NCT05310305` - PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer
Recruiting	`NCT05310357` - Chromosomal Instability in Ovarian Cancer
Recruiting	`NCT05310370` - HRD and Resistance to PAPPi in EOC Patients
Active, not recruiting	`NCT04245644` - Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study
Recruiting	`NCT04245410` - Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma
Completed	`NCT02980185` - Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer	N/A
Recruiting	`NCT03967457` - Comprehensive Study on the Quality of Life in Cervical Cancer Patients
Recruiting	`NCT03892577` - Real-world Study for Patients With Advanced Hepatobiliary Tumors
Completed	`NCT03726021` - Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer	Phase 2
Not yet recruiting	`NCT02942238` - Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)	N/A
Not yet recruiting	`NCT01236989` - Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC	N/A
Recruiting	`NCT05218629` - Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer	Phase 2